Phase 3 Eating Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Binge Eating Disorder (BED) based on standard medical diagnostic guidelines (DSM-5).
- People who are willing and able to give written consent to take part before any study procedures begin.
- People who are male or female, aged between 18 and 55 years old (inclusive).
Who may not be able to join:
- People who have previously taken a medication called solriamfetol (also known as Sunosi), whether through another clinical study or via a prescription.
- People who are unable to follow the study procedures as required.
- People whose doctor or the trial investigator considers them medically unsuitable for participation in this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 212-332-5061
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline to Week 12 in number of binge eating episodes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.